Introduction The digitalization of medicine has led to a considerable growth of
heterogeneous health datasets, which could improve healthcare research if integrated into …

Purpose To assess the efficacy of different preventive dental visits and treatments in
reducing the risk of medication-related osteonecrosis of the jaws (MRONJ). Methods In this …

Il trattamento di ONJ è, dalla sua comparsa in letteratura, argomento molto dibattuto, prima,
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …

(1) Background: Medication-related osteonecrosis of the jaws (MRONJ) is an adverse drug
reaction characterized by progressive bone disruption and necrosis in the mandibular …

Evaluation of Prevalence and Positions of Mesiodens Using Cone-Beam Computed
Tomography - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Background The veteran population has an increasingly high number of patients who have
either survived, are currently living with, or are being treated for prostate cancer …

Objectives Antiresorptive agents for bone pain were widely used to treat patients with
advanced osteoporosis, multiple myeloma, and bone metastatic cancer. In recent years …

Background Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) related to
cancer and myeloma treatments is undetermined, with scarce data varying from 2 to …

Purpose Tori and exostoses are considered risk factors for the development of medication-
related osteonecrosis of the jaw (MRONJ). The aims of this study were to present the …

Background Bisphosphonate (BP) treatment to prevent bone loss in breast cancer patients is
already well established. However, data on the association between oral BP exposure …